| 000 | 01827 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515181232.0 | ||
| 264 | 0 | _c20091124 | |
| 008 | 200911s 0 0 eng d | ||
| 022 | _a1473-4877 | ||
| 024 | 7 |
_a10.1185/03007990903155915 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYe, Xin | |
| 245 | 0 | 0 |
_aAppropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population. _h[electronic resource] |
| 260 |
_bCurrent medical research and opinion _cSep 2009 |
||
| 300 |
_a2251-8 p. _bdigital |
||
| 500 | _aPublication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadministration & dosage |
| 650 | 0 | 4 |
_aAdrenergic Agonists _xadministration & dosage |
| 650 | 0 | 4 | _aAdrenergic beta-2 Receptor Agonists |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Asthmatic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAsthma _xdrug therapy |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aCommerce |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aDrug Utilization _xeconomics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsurance Coverage _xstatistics & numerical data |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPopulation |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aGutierrez, Benjamin | |
| 700 | 1 | _aZarotsky, Victoria | |
| 700 | 1 | _aNelson, Michael | |
| 700 | 1 | _aBlanchette, Christopher M | |
| 773 | 0 |
_tCurrent medical research and opinion _gvol. 25 _gno. 9 _gp. 2251-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1185/03007990903155915 _zAvailable from publisher's website |
| 999 |
_c19030869 _d19030869 |
||